The resulting HSVtk-Fra-1 fusion protein accumulates exclusively in cancer cells overexpressing Fra-1-phosphorylating activity, making these cell populations vulnerable to ganciclovir treatment, while normal cells are spared (Figure 8). This evidence concerns the gene FOSL1 and cancer.